Agoracom Blog Home

Archive for the ‘Enertopia Corp.’ Category

« Older Entries
Newer Entries »

Enertopia Provides Update on The Green Canvas JV

Posted by AGORACOM-JC at 8:04 AM on Tuesday, September 16th, 2014

VANCOUVER, BC / September 16, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) Green Canvas Application is in the Health Canada preliminary screening process.

The company is pleased to advise shareholders that it has been informed by its Joint Venture partner The Green Canvas that they have submitted their application for Licensed Producer and are in correspondence with Health Canada with respect to specific aspects of Quality Assurance Reports which are being handled by their in house PH.D in Organic Chemistry in the application process.

The Green Canvas has applied to produce 10,000 kg of Medical Marihuana per year under its Licensed Producer application. Enertopia may acquire up to a 75% interest in the joint venture as disclosed on February 28, 2014 in our press release 201412.

Facility upgrades are ongoing and Enertopia’s Management team will be onsite in early October and will provide a project update shortly thereafter.

For those new to the Health Canada process for becoming a licensed producer below are the levels to be reached through the application process, Note there are no specific process times for each step:

Step 1: Preliminary Screening
Step 2: Enhanced Screening
Step 3: Security Clearance
Step 4: Review
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Step 7: Licensing

“The Green Canvas is well known and respected in their outreach to patients in need of Medical Marihuana and are respected for producing the highest quality of medical grade marihuana.” Stated President / CEO Robert McAllister.

Further information on the Green Canvas can be found at www.thegreencanvas.ca/

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Green Canvas Joint Venture will obtain a license under MMPR and or that the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Tags: , , , ,
Posted in Enertopia, Enertopia Corp. | Comments Off on Enertopia Provides Update on The Green Canvas JV

Smoking hot marijuana stocks could give investors a buzz

Posted by AGORACOM-JC at 11:41 AM on Tuesday, September 2nd, 2014
Dilys Chan, BNN.ca staff
10:53 AM, E.T. | August 30, 2014
Canadian, Energy & Resources

It’s an exciting time for medical pot in Canada. Two new licensed medical marijuana companies started trading on Monday: OrganiGram Holdings Inc. (OGI.V 2.27 0.02 0.89%) and Bedrocan Cannabis Corp. (BED.V 1.12 0.04 3.7%). They joined Tweed Marijuana Inc. (TWD.V 2.45 -0.02 -0.81%) on the TSX Venture Exchange, bringing the total number of publicly traded marijuana stocks in Canada to three. Both of the new stocks ended the week above their opening prices.

The trend in the commodities space will continue with a fourth company, Mettrum, to hold an IPO in September. According to Khurram Malik, a research analyst at Jacob Securities, the fledgling licensed marijuana industry is at very early stages of enormous growth.

“The [companies] on the Venture exchange with licenses – they’re going to go from $0 to $10 million in revenue pretty quickly in the next year. Tweed’s a perfect example. They’ll have 12 grow rooms up and running by the end of the year,” said Malik.

“The question over the next few months is how quickly suppliers can get their act together and start getting their supply in the market. It is a bit tricky to produce marijuana at a large scale.”

Producers who can ramp up capacity, production and revenue quickly enough can tap into a target market that could potentially generate $1.8 billion in annual revenue, he said to BNN.

The cannabis plant can be a legitimate treatment option for over 100 ailments, said Malik, with pain relief being a common use. With an estimated 500,000 medical pot users in Canada and only 13 suppliers licensed by Health Canada, there is significant demand for product.

“These are very profitable investments for investors to be getting exposure to,” he said.

Investors can compare two key metrics of companies as the industry matures, Malik said. The first is cost to grow product, measured in dollar per gram. The second is how effectively the company acquires customers, a metric that will become more important as producers seek to differentiate themselves from their competition.

Ultimately, Malik thinks marijuana will be legalized, though it’s unclear when that will happen. In the meantime, a regulatory challenge for producers is that they can’t market directly to the consumers or open storefronts. Potential customers need a medical document, similar to a prescription, which then allows them to choose a supplier. But, they have to research and find the supplier on their own. The industry depends on its consumers being self-educating.

Despite that inconvenience, Malik isn’t worried about demand being low for medical pot.

“Buying from the legitimate producers is cheaper, it’s a higher quality and it’s more convenient than going to your proverbial street corner and buying it black market at twice the price.”

Source: http://www.bnn.ca/News/2014/8/30/Smoking-hot-marijuana-stocks-could-give-investors-a-buzz.aspx

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Smoking hot marijuana stocks could give investors a buzz

Enertopia Makes Steady Progress as Industry Heats Up

Posted by AGORACOM-JC at 10:33 AM on Monday, August 25th, 2014

WHITEFISH, MT / August 25, 2014 / Canada’s Marihuana for Medical Purposes Regulations (“MMPR”) program has been mired in controversy since the beginning. After switching from the Medical Marihuana Access Regulations (“MMAR”) to the MMPR program in October 1, 2013, Personal Use Production Licenses (“PUPL”) and Designated Person Production Licenses (“DPPL”) were phased out on March 31, 2014.

The transition from the MMAR to the MMPR program was designed to move marijuana production out of homes and into tightly regulated corporations. Unfortunately, these dynamics translated to an immediate increase in costs for many medical marijuana patients, which led to lawsuits against Health Canada to permit home growing until a better plan was established.

In the meantime, Health Canada has approved 13 licensed producers under the MMPR program that have already begun selling product. These sales are likely to accelerate as the new MMPR program picks up steam, with the government projecting about $1.3 billion per year in revenue by 2024, while home growing operations are likely to end in the near-term following the court resolutions.

Industry Heating Up

The large potential market for licensed producers under the MMPR program has led to tremendous investor interest in the space. With four licensed producers undergoing transactions to become publicly traded, including OrganiGram Inc. (TSX-V: OGI), Mettrum Ltd., Bedrocan Canada Inc., and PharmaCan Capital, investors will have the ability to invest directly or indirectly in seven of the 13 licensed producers.

Tweed Marijuana Inc. (TSX-V: TWD) (OTC: TWJMF) was the first publicly traded licensed producer and has already achieved a market capitalization of over $100 million, as of August 2014. Many private licensed producers have also reported rising demand from fund managers and venture capital firms looking for a piece of the action, signaling investor confidence in the MMPR’s ultimate success.

With many of these publicly traded companies already reaching $50 to $100 million valuations, investors may want to take a look at promising aspiring licensed producers that may be trading at a discount. Diversification across several companies that are approved and/or seeking approval may be the best way to reduce risk in a sector that is characterized by its high volatility.

Making Steady Progress

Enertopia Corp. (OTC: ENRT), with a market cap of only $10.6 million, is an aspiring licensed producer under Canada’s MMPR program that sets itself apart from the competition. With extensive experience under the prior MMAR program, the company has experience growing and handling medical marijuana, unlike many other newer applicants, and regulators know they can trust the firm to deliver on its promises.

CannabisFN Executive Interview | Enertopia Corp. (OTCQB: ENRT) from TDM Financial on Vimeo.

The company’s three major projects are all making steady progress. Security upgrades are being installed at the Green Canvas project in Saskatchewan; design upgrades are in the works at the GTA project in Ontario in partnership with Lexaria Corp. (OTC: LXRP); and, the World of Marijuana project is awaiting its Health Canada site visit as the government continues to work through its backlog.

The company is also actively pursuing opportunities to diversify into related areas like oils, edibles, and industrial hemp markets across North America. Management hopes that these efforts to establish multiple revenue streams will reduce risk for investors and ultimately help internally finance its growth. These efforts also set the company apart from many other pure-plays in the space.

Looking Ahead

Canada’s medical marijuana space may have had a rough start, but the MMPR program appears to be picking up steam. As Health Canada’s site visits take place, many companies are also becoming acquisition targets, as evidenced by Tweed’s acquisition of Park Lane Farms following its approval earlier this month. These dynamics could justify even higher valuations for smaller firms in the space.

Enertopia has a key advantage with its MMAR operating history and experienced management team. As it continues to progress towards licensure, investors in the marijuana space may want to take a second look, including those involved with U.S.-based companies like Medical Marijuana Inc. (OTC: MJNA) or Hemp Inc. (OTC: HEMP), given Canada’s more established federal-level programs.

For more information, see the following resources:

– Company Website – http://www.enertopia.com/

– CannabisFN Profile – http://www.cannabisfn.com/mdc/enertopia-corp/

Sign Up For Future Email Updates On Enertopia Corp.

http://www.tdmfinancial.com/emailassets/enrt/enrt_landing.php

Disclaimer: Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

SOURCE: Emerging Growth LLC

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks | Comments Off on Enertopia Makes Steady Progress as Industry Heats Up

Medical pot cookie prohibition ruled unconstitutional

Posted by AGORACOM-JC at 10:31 AM on Friday, August 15th, 2014

Court challenge stems from B.C. case of Owen Smith, who was charged with trafficking for baking pot cookies

CBC News Posted: Aug 14, 2014 10:42 AM PT Last Updated: Aug 15, 2014 6:35 AM PT

Ban on medical marijuana cookies ruled unconstitutional 1:57

It’s unconstitutional to forbid licensed medical marijuana users from possessing pot-laced products, such as cookies or body creams, a B.C. Court of Appeal judge has ruled.

Parliament has been given one year to recraft regulations to allow medicinal marijuana users to use products made from cannabis extract. They can include creams, salves, oils, brownies, cakes, cookies and chocolate bars.

Health Canada currently allows people suffering from debilitating illnesses access to medicinal marijuana, but only in the form of dried marijuana.

In her written reasons, Justice Risa Levine said this specification “is arbitrary and cannot be justified in a free and democratic society.”

Levine went on to state that when patients choose to use edible forms of marijuana, it “was a matter of necessity, or put another way, the restriction to dried marijuana interfered with their physical or psychological integrity.”

Pot activists react to ruling RAW2:25

Case of the pot cookie baker

The court challenge stems from the case of Owen Smith, who was charged with trafficking for baking pot cookies and producing topical cannabis creams for a medical marijuana club in Victoria in 2009.

Smith was caught baking more than 200 pot cookies for the Victoria Cannabis Buyers Club, and had a supply of cannabis-infused cooking oils and some dried dope in his apartment when he was arrested.

Marijuana ruling - Owen Smith pot cookie bakerOwen Smith was caught baking more than 200 pot cookies for the Victoria Cannabis Buyers Club in 2009. (CHEK)

He was acquitted in April 2012 after the B.C. Supreme Court ruled the medical marijuana regulations were unconstitutional, because patients were denied access to edible pot products and derivatives.

Justice Robert Johnston concluded that permitting dried cannabis alone was arbitrary and did little to further a legitimate state interest.

Thursday’s ruling means Smith acquittal stands and he will not be retried.

Health Minister Rona Ambrose’s office said in a statement released Thursday that it is “reviewing the decision in detail and considering our options.”

Marijuana laws under the microscope

Canada currently prohibits the possession and trafficking of all marijuana products under subsection 4(1) and Schedule II of the Controlled Drugs and Substances Act. However, subsection 55(1) of this act allows for exemptions to be made.

As such, an annex to that act, the Marihuana for Medical Purposes Regulations, allow people with medical need and authorization access to medicinal marijuana.

Under these regulations, many people suffering from debilitating illnesses get marijuana through Health Canada approved companies or get permission to grow it themselves.

However, the MMPR and its predecessor, the MMAR program, limit this access to dried marijuana and do not make any other exceptions to the list of banned substances detailed in Schedule II of the Controlled Drugs and Substances Act.

These banned substances, aside from the exempted dried marijuana, include cannabis resin and various extracts and derivatives of the cannabis plant.

Ottawa had hoped the B.C. Court of Appeal would strike down the B.C. Supreme Court decision.

But under Thursday’s ruling, government has been asked to review these rules, which could mean medical marijuana users would be supplied with resin or extract or be permitted to make themselves products such as pot cookies using marijuana extracts.

RULING | Full B.C. Court of Appeal ruling on medical marijuana extract case

Source: http://www.cbc.ca/news/canada/british-columbia/medical-pot-cookie-prohibition-ruled-unconstitutional-1.2736526

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , ,
Posted in All Recent Posts, Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Medical pot cookie prohibition ruled unconstitutional

Enertopia Provides Corporate Update

Posted by AGORACOM-JC at 8:07 AM on Tuesday, August 5th, 2014

VANCOUVER, BC /August 5, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) announces the following corporate update.

With the recent success of the Burlington municipal approval the Company is pleased to announce it has issued 118,416 shares to 1475714 Ontario Inc. as required under the building lease agreement for its base share of lease costs for the remainder of 2014 under the Lease agreement. The Company and its JV partner Lexaria Corp will have a project update in the coming weeks.

The Company is currently reviewing opportunities in the oil & edibles, and industrial hemp markets across North America, as it looks to broaden its opportunities for multiple streams of revenue.

The Company has also engaged Neil Blake to help out with our Investors Relations outreach.

The Enertopia website has been updated to reflect the company’s growing focus on patient well being as the investment community grows in its understanding of the importance of Medical marijuana and the importance of natural CBD medication, please visit www.enertopia.com

Follow Enertopia:

Twitter: www.twitter.com/EnertopiaCorp

Facebook: www.Facebook.com/EnertopiaCorp

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Burlington JV will obtain a license under MMPR and or that the Company will be able to obtain future financings. Similarly, there can be no assurance that the Company will be successful in securing operations in the oils, edibles or hemp markets.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Provides Corporate Update

Parents of six-year-old medical marijuana user calling for legal access to marijuana oil

Posted by AGORACOM-JC at 10:11 AM on Tuesday, July 29th, 2014

CTV Ottawa

The parents of six-year-old Ottawa Constance Bay boy who suffers from a rare form of epilepsy are desperately calling for changes to Canada’s medicinal marijuana laws.

Liam McKnight’s parents are breaking the rule by giving him marijuana oil to help treat his severe seizures.

Liam has Dravet Syndrome, a rare form of epilepsy that causes him to suffer violent seizures, sometimes dozens a day.

But under Heath Canada rules, licensed producers can only produce and distribute dried marijuana.

Liam’s mother Mandy McKnight says her son is technically only allowed to smoke it or vaporize it.

But she doesn’t want Liam smoking marijuana, and she says he wouldn’t be able to anyway.

Liam is developmentally delayed, and his mother says he would not understand how to inhale it.

McKnight says the best way for Liam to receive the medical benifits of the drug is to ingest it as an oil, not to smoke it.

The strain of marijuana Liam is taking is higher in CBD, the compound that helps him, and very low in THC, the compound that produces the drug’s “high” effects.

Liam’s mom says they have tried several different medications to treat Liam’s seizures, and so far marijuana oil has been their best defence against them.

Liam’s parents are calling on the federal government to make medicinal marijuana oil legal.

Right now, they must go through the costly and lengthy process of buying the dried marijuana, having it converted into oil, then tested to check its properties so they can determine the proper dosage to give Liam.

They say they don’t know how long they can sustain that.

According to Health Canada, “current regulations for clinical trials would allow a sponsor to propose a clinical trial for extracts of cannabis. A manufacturer or another sponsor (e.g., a physician or treatment centre) can submit a clinical trial application to Health Canada at any time.”

But the McNights say they don’t have time to wait for a clinical trial.

They say last year, 14 children in their Dravet Syndrome support group passed away.

They want Liam to have easier access to the oil so his quality of life can be improved.
“I don’t understand why Health Canada is preventing him from accessing a medication that could potentially save his life, or extend it for a very long period of time,” Mandy McKnight said.

“We’re trying to do everything we can to just give him a break, and give him a chance to just be a kid,” she said. “I think it’s a viable treatment option, and he deserves a chance to try it.”

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , ,
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Parents of six-year-old medical marijuana user calling for legal access to marijuana oil

Enertopia Announces AGM Results

Posted by AGORACOM-JC at 8:06 AM on Wednesday, July 23rd, 2014

 

Vancouver, BC /July 23 2014 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce all resolutions were approved and adopted at its Annual General Meeting (AGM) held on July 15th.

Re-election of directors was approved with the following results:

Nominee For Withhold Not Voted
Robert McAllister 18,929,105 (99.41%) 113,264 (0.59%) 11,529,448
Donald Findlay 18,963,169 (99.58%) 79,200 (0.42%) 11,529,448
John Thomas 19,000,854 (99.78%) 41,515 (0.22%) 11,529,448
Mathew Chadwick 2,084,772 (10.95%) 16,957,597 (89.05%) 11,529,448

 

-Ratification of MNP LLP our independent registered public accounting firm to hold office until the close of the next annual general meeting and to allow directors to set the remuneration, approved with 30,286,680 votes For (99.07%), 285,136 votes Against (0.93%) and 1 vote Not Voted; and

-Ratification of the change of business to the regulated marijuana industry was passed with 19,029,444 votes For (99.93%), 12,925 votes Against (0.07%), and 11,529,448 Not Voted; and

-Shareholders approved the compensation of our company’s named executive officers (Say-On-Pay), by a vote of 19,008,019 votes For (99.82%), 34,350 votes Against (0.18%), and 11,554,370 Not Voted; and

-Shareholders approved a 3-year frequency (Say-When-On-Pay) of future advisory votes on the compensation of our company’s named executive officers, by the following votes One Year – 1,452,183, Two Years – 74,858 Three Years – 17,490,406, Not Voted – 11,554,370; and

-Ratification of the Company’s 2014 stock option plan was passed with 18,996,969 votes For (99.76%), 45,400 votes Against (0.24%), and 11,529,448 Not Voted.

The Company also notes that 252,000 warrants have been exercised raising $25,200 in net proceeds.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in the USA with symbol ENRT and in Canada with symbol TOP.

To learn more about Enertopia Corp. visit www.enertopia.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Announces AGM Results

Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia

Posted by AGORACOM-JC at 10:25 AM on Tuesday, July 22nd, 2014

WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component of the index, also fell over 5% last week.

Top gainers last week included Nuvilex Inc. (OTC: NVLX), which jumped more than 16.5% after reporting positive results in dogs for its anticancer treatment, Enertopia Corp. (OTC: ENRT), which jumped more than 13% after receiving municipal approval for its MMPR joint venture in Burlington, Ontario, and Novus Acquisition & Development Corp. (OTC: NDEV), which rose more than 12% last week.

Cannabis regulatory initiatives also gained ground last week. In a favorable swing, the U.S. House of Representatives voted to support making it easier for cannabis-related companies to access the commercial banking sector. A new survey also found that U.S. citizens are increasingly embracing both medical and recreational marijuana following the successful rollout of both programs in several states.

What’s New?

– CannLabs Continues to Make Tremendous Strides – CannLabs Inc. (OTC: CANL) recently announced the addition of industry experts to its leadership team, updates to its services to accommodate new Colorado MED testing requirements, and a new ticker symbol.

– West Point Starts Cannabis Breathalyzer Development – West Point Resources Inc. (CNSX: BLO) recently announced that it has selected a prototype development firm to complete the initial version of its Cannabix Marijuana Breathalyzer in partnership with its engineering team.

– A Supreme Opportunity in the Cannabis Space – CannabisFN takes a look at Supreme Pharmaceuticals Inc. (OTC: SPRWF) and its low-risk, high-reward strategy for obtaining licensed producer status from Health Canada under the country’s new MMPR framework introduced this year.

– House Votes to Allow Marijuana-Related Banking – The U.S. House of Representatives voted 236-186 in support of making it easier for cannabis-related businesses to work with commercial banks, a problem that has caused some marijuana businesses to become criminal targets.

– Cannabis Therapy’s Multi-Pronged Approach – CannabisFN takes a look at Cannabis Therapy Inc.’s (OTC: CTCO) unique business strategy, existing hemp cultivation, and why their laboratory research could be a significant catalyst for the stock over the coming quarters.

– Capitalize on the Green Rush with DigiPath – CannabisFN takes a look at DigiPath Inc. (OTC: DIGP) and its unique and synergistic plans within the cannabis industry focusing on laboratory testing, training/education, and cannabis-related media ventures.

What to Watch This Week

The cannabis sector continues to move higher, as it recovers from its lows made earlier this year. In Canada, investors are still waiting for MMPR licensing decisions to be made for several companies, while keeping an eye on the injunction that’s keeping the country’s MMAR program alive for now. In the U.S., regulators appear to be increasingly supportive of cannabis, as state-wide experiments continue to be positive in terms of both public safety and tax revenue from cannabis.

About CannabisFN

CannabisFN.com is a dedicated financial network covering new, emerging and established companies operating in the burgeoning multi-billion dollar medical marijuana (“MMJ”) and cannabis industries. CannabisFN’s coverage is syndicated on the leading industry specific and mainstream financial websites and social media. To learn more and request a media kit, visit http://www.cannabisfn.com/market-defining-companies-program/.

To subscribe to the CannabisFN newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , ,
Posted in Enertopia Corp. | Comments Off on Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia

Toronto opens first referral-only medical marijuana clinic

Posted by AGORACOM-JC at 11:26 AM on Monday, July 21st, 2014

BLAKE WOLFE | QMI AGENCY

TORONTO – Inside a brand-new medical clinic near the intersection of Yonge St. and Eglinton Ave., a patient walks up to the counter following his appointment.

An employee stands with him, offering advice on the man’s new medication.

“Be sure to grind it well before putting consuming it,” the staffer says. “You want it fluffy like dryer lint. Fluffy is your friend when it comes to vaporizers.”

The patient thanks him for the advice and heads out the door.

It’s a normal exchange at the Cannabinoid Medical Clinic — CMClinic for short — Toronto’s first referral-only medical marijuana clinic.

It was a busy first week for executive director Dr. Danial Schecter and his staff after officially opening the clinic’s doors on July 14 and seeing dozens of the approximately 700 patients on the wait list. Talk of additional clinics in Canada is already taking place, Schecter says.

The clinic opened in the wake of new federal regulations regarding medical marijuana use. The rules, which came into effect on April 1, require that patients procure their stash from an approved supplier with a doctor’s prescription.

Schecter, who learned of marijuana’s medical effects while studying at the University of Montreal, set up the Toronto clinic after successfully using the plant to treat several patients at his former practice near Georgian Bay.

“I had a patient who suffered from anxiety so badly that he literally flapped when he walked into my office,” recalled Schecter, adding that the man self-medicated with alcohol and was afraid to consume marijuana for fear of returning to prison. “I saw his treatment as a success, and when the new regulations were announced, it was an opportunity to help many more people.”

Despite criticism from some doctors and health organizations about the lack of evidence for marijuana’s medical benefits, Schecter said he hopes to change that perception by contributing to the emerging field through his work at the clinic. He explained that in his experience, family doctors fall into three categories:

The 10% who are firmly opposed to the medical use of weed, another 10% who are open to the concept but cautious, and the 80% who are willing to prescribe it as a last resort for patients who have tried everything else.

“This is something that’s talked about for maybe five or 10 minutes in medical school,” Schecter mused. “The research done here will allow us to make a solid contribution to a novel field of medicine. I’m trying to educate the skeptical physicians and help that 80% (willing to prescribe marijuana).”

While other marijuana clinics have recently sprung up in Toronto, Schecter is quick to point out that CMClinic is referral-only and is covered through OHIP, similar to other medical specialists that a patient may be referred to by their family doctor.

Clinic spokesman Bridget Best said the facility operates more as a referral and educational centre for doctors and patients who may need assistance in learning about the various forms that cannabis can take as well as the myriad consumption methods.

Schecter said that as opposed to the typical recreational user who may consume mass quantities of weed due to tolerance of the drug, his patients often manage their pain by using less than a gram per day.

While patients are free to consume marijuana in whichever way they choose, the clinic sells vaporizers (which create marijuana vapour instead of smoke) as opposed to typical head shop fare like glass pipes and bongs.

No marijuana is stored on site, Best said.

Pursuing a medication more often associated with recreational and illicit consumption is often a last resort for most of the clinic’s patients — many of whom hail from various points across the GTA and southern Ontario, while others still have inquired from as far away as Germany and Panama.

Schecter, who said that he tries to avoid prescribing pot to anyone under 25 due to the inconclusive effects of the drug on the growing brain, deals predominantly with patients in “chronic pain,” ranging from those suffering with the lingering effects of accidents and chemotherapy to those requiring palliative care.

Travelling to the clinic from Bowmanville, patient Bob Landry recalled the 2011 traffic accident that left him with lingering pain and headaches. While Landry said that he has successfully used marijuana to treat his condition after traditional prescription drugs proved either ineffective or unthinkable, he sought out the clinic to help with proper dosages.

“I tried normal painkillers first, then my doctor offered me Oxycontin — I refused,” Landry said, explaining that his cousin had died from the controversial drug. “I believe this is the solution. I prefer to acquire it legally and, this way, I know what I’m getting.

“I hope to one day return to my normal activities.”

Source: http://www.sunnewsnetwork.ca/sunnews/canada/archives/2014/07/20140720-162102.html

Tags: , , ,
Posted in Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Toronto opens first referral-only medical marijuana clinic

A Closer Look at Enertopia’s Three MMJ Projects

Posted by AGORACOM-JC at 10:00 AM on Monday, June 23rd, 2014

WHITEFISH, MT / June 23, 2014 / Canada’s Marijuana for Medical Purposes Regulations (“MMPR”) has attracted a lot of investor interest, as evidenced by Tweed Marijuana Inc.’s (TSX-V: TWD) (OTC: TWMJF) nearly $100 million market capitalization. Health Canada estimates that the market for legalized marijuana could surpass $1.3 billion with 450,000 patients over the next ten years, while adult use legalization could eventually add to the total.

With only 13 licensed producers under the MMPR program, investors have the choice of either investing in a handful of approved licensed producers, like Tweed, or investing in companies pursuing a license. Those pursuing a license could offer greater upside given Tweed’s $100 million plus valuation, with some companies pursuing licenses trading in the sub-$15 million price range.

Enertopia Corp. (OTC: ENRT) (CSE: TOP) is one of the companies pursuing a license with three separate projects in its pipeline. With its diverse exposure, the company’s experienced management team aims to increase its odds of success in obtaining an MMPR license. The three projects also have a combined capacity of about 64,000 net square feet of production space, which would make it among the larger producers.

Also See: Enertopia Corp.’s Exclusive Interview with CannabisFN

Green Canvas Facility

In February 2014, Enertopia announced a joint venture whereby it acquired 75% of Green Canvas for C$1 million and 19 million shares over a three-year period. The Saskatchewan-based facility will have an initial build-out of 14,000 square feet of grow space, which could eventually be scaled to 55,000 square feet.

The Green Canvas Facility is currently a producer under the existing MMAR program, which should help the application for their MMPR license to be approved. The facility has recently undergone security upgrades and is awaiting further review from the Health Canada before taking the next step forward.

Green Canvas facility is currently undergoing renovations and security upgrades. $50,000 was recently spent on the perimeter fencing alone to be compliant with the stringent Health Canada security guidelines. New cement floors were recently poured for the lab and security storage area. Quotes are now being received for the buildup phase one construction for the production rooms.

GTA Facility

In May 2014, Enertopia signed the definitive joint venture agreement with Lexaria Corp. (CSE: LXX) for the upgrade of a Greater Toronto Area-based facility. Enertopia would own a 51% interest in the production facility, and pay 45% of the ongoing costs in addition to receiving a one-time payment of 500,000 shares of restricted Lexaria stock. The 30,000 square foot facility also has a right of first refusal on an additional 45,000 square feet.

Currently, the facility is awaiting municipal approval for a facility build-out that management expects will take approximately three months. In the meantime, the company plans to submit a building permit in July 2014 and seek MMPR approval thereafter in order to become a licensed producer. The sheer size and potential for expansion could make it one of Canada’s top tier growing facilities, if approved.

The GTA facility is being planned out to be the Company’s flagship project in Canada. Building design is in the final stages, this will include state of the art laboratory facility that will be one of the key components in cannabis research going forward for the Company.

World of Marihuana Facility

In January 2014, Enertopia announced a joint venture with an option to earn up to 51% net revenue interest in the World of Marihuana project in British Columbia. This project also already grows under the Medical Marihuana Access Program (“MMAR”) with 2,500 square feet of production. The facility is currently producing five to six popular cannabis strains.

World of Marihuana applied to the MMPR program in October 2013 and is awaiting a Health Canada site visit. If approved, the existing 2,500 square feet could generate $1,100 in gross revenue per square foot per year.

As an existing producer under the MMAR, the project could also be more likely to be approved than many other MMPR applicants starting from scratch. The discount rates on these valuations could therefore be lower than some competitors.

Looking Ahead

Enertopia is unique among aspiring licensed producers under Canada’s MMPR system due to its three distinct projects located across different parts of Canada. If approved, these three projects could start generating in a little over three months from receiving Health Canada licensed approvals. The long-term potential for these projects is even greater given the many opportunities for expansion.

Investors in aspiring MMPR licensed producers, including Creative Edge Nutrition Inc. (OTC: FITX), Medican Enterprises Inc. (OTC: MDCN), or Modern Mobility Aids (OTC: MDRM), may want to also take a look at Enertopia given its diverse focus, previous MMAR statuses, and significant production capacity.

Click Here To Sign Up For Future Email Updates On Enertopia Corp.

http://www.tdmfinancial.com/emailassets/enrt/enrt_landing.php

For more information, see the following resources:

– Company Website – http://www.enertopia.com/s/Home.asp
– Investor Presentation – http://www.enertopia.com/i/pdf/Enertopia_Presentation_May_2014.pdf
– OTC Markets Profile – http://www.otcmarkets.com/stock/ENRT/quote

 

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

SOURCE: Emerging Growth LLC

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks | Comments Off on A Closer Look at Enertopia’s Three MMJ Projects

« Older Entries
Newer Entries »